pancretatic cancer
Conditions
Interventions
Pancreatectomy for the patients with disease control with chemotherapy for more than 3 months
Sponsors
Department of surgery, Tohoku university school of medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) histolycally proven invasive pancreatic ductal adenocarcinoma (2) the number of intraabdominal distant metastasis is 5 or less, and all of them were removed for histological diagnosis at laparotomy (3)no distant metastasis with preoperative imaging (CT, MRI, FDG-PET-CT) (4) R01 resection is possible for primary cancer (5) with tolerable health to operation (6) no prior therapy for pancreas cancer except for metastatectomy at 1st laparotomy (7) not enrolled in other study with primary endpoint of resection or survival (8) no other active cancer (9) expect survival time is 6-month and more (10) with consent in a writing form (11) 20 years old or older with judgement
Exclusion criteria
Exclusion criteria: (1) not diagnosed as invasive pancreatic ductal adenocarcinoma (2) the number of distant metastasis is 6 or more (3) with detectable distant metastasis by preoperative image (4) R2 resection is expected (5) without tlerable health to operation (6) recurrent pancreatic cancer (7) enrolled in other study with primary endpoint of resection or survival (8) with another active cancer (9) with uncontrollable infection (10) in pregnancy (11) expected survival time is less than 6 months (12) chemotherapy is difficult (13) younger than 20 years old (14) without judgement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| survival rate at 2-year. | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival recurrent free survival at 1-year R0 resection rate pattern of recurrence tumor marker | — |
Countries
Japan
Contacts
Public ContactHiroki Hayashi
Tohoku University Surgery
Outcome results
None listed